Latest News
3 Magnificent Stocks Under $100 to Buy in November
The price could be right for these stocks.
Exelixis (EXEL) Q3 2024 Earnings Call Transcript
EXEL earnings call for the period ending September 30, 2024.
1 No-Brainer Stock to Buy With $40
The midcap biotech just became an even better buy.
2 Growth Stocks to Buy With Less Than $100
No need to break the bank to get in on these likely long-term winners.
Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – The surge in global cancer cases is raising...
Exelixis (EXEL) Q2 2024 Earnings Call Transcript
EXEL earnings call for the period ending June 30, 2024.
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development
USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million new cancer cases. In order to respond to the rising rates of cancer, the National Cancer...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
These stocks are both experts in their respective fields.
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
EXEL earnings call for the period ending March 31, 2024.
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high.
2 Biotech Stocks to Buy Hand Over Fist in March
These stocks are worth buying in most months of the year.
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found.
2 Stocks Under $30 to Buy and Hold
You don't need to be a millionaire to get started. Investing on a budget can work, too.
4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The growth-driven Nasdaq Composite hasn't put the 2022 bear market entirely in the rearview mirror, which means opportunistic investors can still find bargains.
Exelixis (EXEL) Q4 2023 Earnings Call Transcript
EXEL earnings call for the period ending December 31, 2023.
We are looking for U.S. companies with a history of robust free-cash-flow-to-capital
Exelixis (EXEL) Q3 2023 Earnings Call Transcript
EXEL earnings call for the period ending September 30, 2023.
4 Dominant Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
Bargains abound for growth-seeking investors, with the Nasdaq Composite still 20% below its record-closing high.
3 Under-the-Radar Biotech Stocks to Buy in 2023
These three lesser-known biotech companies are profitable and growing revenue.
Is Exelixis Stock a Buy Now?
There is one key reason to consider the stock.
4 Magnificent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
A 14% decline in the Nasdaq Composite represents the perfect opportunity for investors to pounce.
2 Top Biotech Stocks Defying the Bear Market
The best may be yet to come for these companies.
The Top Healthcare Stocks to Buy With $100
Both stocks have outperformed the broader market in the last 12 months.
2 No-Brainer Biotech Stocks to Buy Right Now
These two companies make a compelling case for a high price.